Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q2 2026
Institutional positions in Kezar Life Sciences, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KZR is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 0
- −43 vs. Q1 2026
- Shares held
- 0
- −4.43M (−100.0%) vs. Q1 2026
- Total value
- $0
- −$32.8M (−100.0%) vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 43
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 0 | $0 | 0.00% | −720,787−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −716,759−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −664,314−100.0% | Sold out |
| Vanguard Capital Management LLC | 0 | $0 | 0.00% | −290,529−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −243,073−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −229,076−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −188,426−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −151,630−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −142,050−100.0% | Sold out |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −126,692−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −102,211−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −100,064−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −81,933−100.0% | Sold out |
| Groupe la Francaise | 0 | $0 | 0.00% | −80,400−100.0% | Sold out |
| Aldebaran Capital, LLC | 0 | $0 | 0.00% | −80,335−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −60,988−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −59,403−100.0% | Sold out |
| Credit Industriel Et Commercial | 0 | $0 | 0.00% | −53,600−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −48,479−100.0% | Sold out |
| Vanguard Fiduciary Trust Co | 0 | $0 | 0.00% | −41,201−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −30,334−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −28,144−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −27,093−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Vazirani Asset Management LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,367−100.0% | Sold out |
| Equitec Proprietary Markets, LLC | 0 | $0 | 0.00% | −19,500−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,495−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −16,210−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −13,763−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10,208−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,796−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −4,285−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −2,176−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −1,737−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −308−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −322−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −262−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |